Search research articles
Contact Us
Filters
Showing results (41-50 of 970) with videos related to
Page
of 97
Sort By:
Hepatobiliary Surgery and Nutrition
|
June 11, 2026
Hepatocellular carcinoma surveillance-is it time to update clinical practice?
Jessica Yang, Jacob George
Australian Prescriber
|
March 6, 2024
Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building
Varan Perananthan, Jacob George
Expert Opinion on Therapeutic Targets
|
September 30, 2016
Targeting IFN-λ: therapeutic implications
Mohammed Eslam, Jacob George
Hepatology (Baltimore, Md.)
|
June 22, 2013
Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?
Francisco Barrera, Jacob George
Therapeutics and Clinical Risk Management
|
October 24, 2009
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Jacob George, Allan Struthers
Hepatology International
|
June 17, 2024
MAFLD: from a disease framework to patient care
Mohammed Eslam, Jacob George
Journal of the American College of Cardiology
|
June 23, 2009
The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) trial: a question of dose
Jacob George, Allan Struthers
Nature Reviews. Gastroenterology & Hepatology
|
December 2, 2010
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard, Jacob George
Sports Medicine - Open
|
October 18, 2016
A Descriptive Study of Hot Aches: a Previously Unreported Winter Climbing Phenomenon
Andrew Melvin, Jacob George
Australian Journal of General Practice
|
September 30, 2021
Updates in fatty liver disease: Pathophysiology, diagnosis and management
Cameron Gofton, Jacob George
Page
of 97
Search research articles
Search
Showing results (41-50 of 970) with videos related to
Sort By:
Page
of 97
Hepatobiliary Surgery and Nutrition
|
June 11, 2026
Hepatocellular carcinoma surveillance-is it time to update clinical practice?
Jessica Yang, Jacob George
Australian Prescriber
|
March 6, 2024
Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building
Varan Perananthan, Jacob George
Expert Opinion on Therapeutic Targets
|
September 30, 2016
Targeting IFN-λ: therapeutic implications
Mohammed Eslam, Jacob George
Hepatology (Baltimore, Md.)
|
June 22, 2013
Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?
Francisco Barrera, Jacob George
Therapeutics and Clinical Risk Management
|
October 24, 2009
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Jacob George, Allan Struthers
Hepatology International
|
June 17, 2024
MAFLD: from a disease framework to patient care
Mohammed Eslam, Jacob George
Journal of the American College of Cardiology
|
June 23, 2009
The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) trial: a question of dose
Jacob George, Allan Struthers
Nature Reviews. Gastroenterology & Hepatology
|
December 2, 2010
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard, Jacob George
Sports Medicine - Open
|
October 18, 2016
A Descriptive Study of Hot Aches: a Previously Unreported Winter Climbing Phenomenon
Andrew Melvin, Jacob George
Australian Journal of General Practice
|
September 30, 2021
Updates in fatty liver disease: Pathophysiology, diagnosis and management
Cameron Gofton, Jacob George
Page
of 97